Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
45,017,464
-
Share change
-
-240,660
-
Total reported value
-
$854,951,019
-
Put/Call ratio
-
65%
-
Price per share
-
$18.99
-
Number of holders
-
98
-
Value change
-
-$8,625,778
-
Number of buys
-
46
-
Number of sells
-
52
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2016
As of 31 Mar 2016 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,017,464 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, FMR LLC, TANG CAPITAL MANAGEMENT LLC, JANUS CAPITAL MANAGEMENT LLC, Invesco Ltd., Partner Fund Management, L.P., BAKER BROS. ADVISORS LP, Cormorant Asset Management, LLC, Broadfin Capital, LLC, and STATE STREET CORP.
This table shows 98 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.